These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3166906)

  • 1. Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation.
    McCulloch P; George WD
    Br J Cancer; 1988 Aug; 58(2):158-62. PubMed ID: 3166906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of pulmonary tumour seeding by human coagulation factors II, IX, X--an investigation into the possible mechanisms involved.
    Purushotham AD; McCulloch P; George WD
    Br J Cancer; 1991 Sep; 64(3):513-7. PubMed ID: 1911192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin inhibition of metastasis: the role of anticoagulation.
    McCulloch P; George WD
    Br J Surg; 1987 Oct; 74(10):879-83. PubMed ID: 3664218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets. Characterization and relationship to fibrin deposition and fibrosis.
    Idell S; Gonzalez KK; MacArthur CK; Gillies C; Walsh PN; McLarty J; Thrall RS
    Am Rev Respir Dis; 1987 Jul; 136(1):124-33. PubMed ID: 2440356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
    Francis JL; Carty N; Amirkhosravi M; Loizidou M; Cooper A; Taylor I
    Br J Cancer; 1992 Mar; 65(3):329-34. PubMed ID: 1558784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth.
    McCulloch P; George WD
    Br J Cancer; 1989 Feb; 59(2):179-83. PubMed ID: 2930682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An endothelial cell-dependent pathway of coagulation.
    Stern D; Nawroth P; Handley D; Kisiel W
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2523-7. PubMed ID: 3873069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo defibrination results in markedly decreased amounts of fibrinogen in rat megakaryocytes and platelets.
    Handagama PJ; Shuman MA; Bainton DF
    Am J Pathol; 1990 Dec; 137(6):1393-9. PubMed ID: 2260627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptokinase inhibits pulmonary tumor seeding in an animal experimental model.
    Purushotham AD; Brown DC; McCulloch P; Choy A; George WD
    J Surg Oncol; 1994 Sep; 57(1):3-7. PubMed ID: 8065148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
    Xi M; Béguin S; Hemker HC
    Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo.
    Amirkhosravi M; Francis JL
    Br J Haematol; 1993 Dec; 85(4):736-44. PubMed ID: 7918038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation.
    De Curtis A; D'Adamo MC; Amore C; Polishchuck R; Castelnuovo AD; Donati MB; Iacoviello L
    Thromb Haemost; 2001 Dec; 86(6):1440-8. PubMed ID: 11776312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis.
    Cunningham MA; Kitching AR; Tipping PG; Holdsworth SR
    Kidney Int; 2004 Aug; 66(2):647-54. PubMed ID: 15253718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation.
    Amirkhosravi M; Francis JL
    Thromb Haemost; 1995 Jan; 73(1):59-65. PubMed ID: 7740497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation.
    Pollak VE; Glueck HI; Weiss MA; Lebron-Berges A; Miller MA
    Am J Nephrol; 1982; 2(4):195-207. PubMed ID: 6816068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential release of active proteinase inhibitors by two rat mammary adenocarcinoma variants possessing different metastatic potentials.
    Neri A; Bohoslawec O; Anderson TD; Tokes ZA
    Cancer Res; 1991 Feb; 51(4):1318-25. PubMed ID: 1997170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.